Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
6,982
archived clinical trials in
Endocrine

Effect of Whole Grain Diet on Insulin Sensitivity, Advanced Glycation End Products and Inflammatory Markers in Pre-diabetes
Effect of Whole Grain Diet on Insulin Sensitivity, Advanced Glycation End Products and Inflammatory Markers in Pre-diabetes
Status: Archived
Mount Sinai Hospital
1289
mi
from
New York, NY
Effect of Whole Grain Diet on Insulin Sensitivity, Advanced Glycation End Products and Inflammatory Markers in Pre-diabetes
Effect of Whole Grain Diet on Insulin Sensitivity, Advanced Glycation End Products and Inflammatory Markers in Pre-diabetes
Status: Archived
Updated: 1/1/1970
Mount Sinai Hospital
1289
mi
from
New York, NY
Is Fructose Linked to Adiposity in Babies?
Is Fructose Linked to Adiposity in Babies?
Status: Archived
San Francisco General Hospital
1339
mi
from
San Francisco, CA
Is Fructose Linked to Adiposity in Babies?
Is Fructose Linked to Adiposity in Babies?
Status: Archived
Updated: 1/1/1970
San Francisco General Hospital
1339
mi
from
San Francisco, CA
Growth Hormone Therapy in Osteogenesis Imperfecta
Studies of Growth Deficiency and Growth Hormone Treatment in Children With Osteogenesis Imperfecta Types III and IV
Status: Enrolling
Updated:  12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
1123
mi
from
Bethesda, MD
Growth Hormone Therapy in Osteogenesis Imperfecta
Studies of Growth Deficiency and Growth Hormone Treatment in Children With Osteogenesis Imperfecta Types III and IV
Status: Enrolling
Updated: 12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
1123
mi
from
Bethesda, MD
Click here to add this to my saved trials
Evaluation and Intervention for the Effects of Osteogenesis Imperfecta
Evaluation and Intervention for Ambulation, Growth, and Basilar Invagination in Osteogenesis Imperfecta
Status: Enrolling
Updated:  12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
1123
mi
from
Bethesda, MD
Evaluation and Intervention for the Effects of Osteogenesis Imperfecta
Evaluation and Intervention for Ambulation, Growth, and Basilar Invagination in Osteogenesis Imperfecta
Status: Enrolling
Updated: 12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
1123
mi
from
Bethesda, MD
Click here to add this to my saved trials
The Treatment and Natural History of Acromegaly
Acromegaly Treatment and Natural History
Status: Enrolling
Updated:  12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
1123
mi
from
Bethesda, MD
The Treatment and Natural History of Acromegaly
Acromegaly Treatment and Natural History
Status: Enrolling
Updated: 12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
1123
mi
from
Bethesda, MD
Click here to add this to my saved trials
Study of Thyrotropin-Releasing Hormone in Normal Volunteers and in Patients With Thyroid or Pituitary Abnormalities
Study of Thyrotropin Releasing Hormone in Patients With Thyroid or Pituitary Abnormalities
Status: Enrolling
Updated:  12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
1123
mi
from
Bethesda, MD
Study of Thyrotropin-Releasing Hormone in Normal Volunteers and in Patients With Thyroid or Pituitary Abnormalities
Study of Thyrotropin Releasing Hormone in Patients With Thyroid or Pituitary Abnormalities
Status: Enrolling
Updated: 12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
1123
mi
from
Bethesda, MD
Click here to add this to my saved trials
Hormonal Causes of Menstrual-Related Mood Disorders
5HT1A and SERT Imaging During Pharmacologically Induced Hypogonadotropic Hypogonadism With and Without Estrogen and Progesterone Replacement
Status: Enrolling
Updated:  12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
1123
mi
from
Bethesda, MD
Hormonal Causes of Menstrual-Related Mood Disorders
5HT1A and SERT Imaging During Pharmacologically Induced Hypogonadotropic Hypogonadism With and Without Estrogen and Progesterone Replacement
Status: Enrolling
Updated: 12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
1123
mi
from
Bethesda, MD
Click here to add this to my saved trials
Effects of Aromatase Inhibition Versus Testosterone in Older Men With Low Testosterone: Randomized-Controlled Trial.
The Effects of Aromatase Inhibition and Testosterone Replacement in Sex Steroids, Pituitary Hormones, Markers of Bone Turnover, Muscle Strength, and Cognition in Older Men
Status: Enrolling
Updated:  12/31/1969
National Institute of Aging, Clinical Research Unit
1151
mi
from
Baltimore, MD
Effects of Aromatase Inhibition Versus Testosterone in Older Men With Low Testosterone: Randomized-Controlled Trial.
The Effects of Aromatase Inhibition and Testosterone Replacement in Sex Steroids, Pituitary Hormones, Markers of Bone Turnover, Muscle Strength, and Cognition in Older Men
Status: Enrolling
Updated: 12/31/1969
National Institute of Aging, Clinical Research Unit
1151
mi
from
Baltimore, MD
Click here to add this to my saved trials
Bortezomib in Treating Patients With Metastatic Thyroid Cancer That Did Not Respond to Radioactive Iodine Therapy
A Phase II Study of Bortezomib in Metastatic Papillary Thyroid Carcinoma or Follicular Thyroid Carcinoma
Status: Enrolling
Updated:  12/31/1969
Univ. of Colorado at Denver and Health Sciences Center
402
mi
from
Aurora, CO
Bortezomib in Treating Patients With Metastatic Thyroid Cancer That Did Not Respond to Radioactive Iodine Therapy
A Phase II Study of Bortezomib in Metastatic Papillary Thyroid Carcinoma or Follicular Thyroid Carcinoma
Status: Enrolling
Updated: 12/31/1969
Univ. of Colorado at Denver and Health Sciences Center
402
mi
from
Aurora, CO
Click here to add this to my saved trials
Bortezomib in Treating Patients With Metastatic Thyroid Cancer That Did Not Respond to Radioactive Iodine Therapy
A Phase II Study of Bortezomib in Metastatic Papillary Thyroid Carcinoma or Follicular Thyroid Carcinoma
Status: Enrolling
Updated:  12/31/1969
Lombardi Comprehensive Cancer Center at Georgetown University
1125
mi
from
Washington,
Bortezomib in Treating Patients With Metastatic Thyroid Cancer That Did Not Respond to Radioactive Iodine Therapy
A Phase II Study of Bortezomib in Metastatic Papillary Thyroid Carcinoma or Follicular Thyroid Carcinoma
Status: Enrolling
Updated: 12/31/1969
Lombardi Comprehensive Cancer Center at Georgetown University
1125
mi
from
Washington,
Click here to add this to my saved trials
Bortezomib in Treating Patients With Metastatic Thyroid Cancer That Did Not Respond to Radioactive Iodine Therapy
A Phase II Study of Bortezomib in Metastatic Papillary Thyroid Carcinoma or Follicular Thyroid Carcinoma
Status: Enrolling
Updated:  12/31/1969
Emory University
801
mi
from
Atlanta, GA
Bortezomib in Treating Patients With Metastatic Thyroid Cancer That Did Not Respond to Radioactive Iodine Therapy
A Phase II Study of Bortezomib in Metastatic Papillary Thyroid Carcinoma or Follicular Thyroid Carcinoma
Status: Enrolling
Updated: 12/31/1969
Emory University
801
mi
from
Atlanta, GA
Click here to add this to my saved trials
Bortezomib in Treating Patients With Metastatic Thyroid Cancer That Did Not Respond to Radioactive Iodine Therapy
A Phase II Study of Bortezomib in Metastatic Papillary Thyroid Carcinoma or Follicular Thyroid Carcinoma
Status: Enrolling
Updated:  12/31/1969
Massachusetts General Hospital Cancer Center
1444
mi
from
Boston, MA
Bortezomib in Treating Patients With Metastatic Thyroid Cancer That Did Not Respond to Radioactive Iodine Therapy
A Phase II Study of Bortezomib in Metastatic Papillary Thyroid Carcinoma or Follicular Thyroid Carcinoma
Status: Enrolling
Updated: 12/31/1969
Massachusetts General Hospital Cancer Center
1444
mi
from
Boston, MA
Click here to add this to my saved trials
Bortezomib in Treating Patients With Metastatic Thyroid Cancer That Did Not Respond to Radioactive Iodine Therapy
A Phase II Study of Bortezomib in Metastatic Papillary Thyroid Carcinoma or Follicular Thyroid Carcinoma
Status: Enrolling
Updated:  12/31/1969
Dana-Farber / Harvard Cancer Center
1444
mi
from
Boston, MA
Bortezomib in Treating Patients With Metastatic Thyroid Cancer That Did Not Respond to Radioactive Iodine Therapy
A Phase II Study of Bortezomib in Metastatic Papillary Thyroid Carcinoma or Follicular Thyroid Carcinoma
Status: Enrolling
Updated: 12/31/1969
Dana-Farber / Harvard Cancer Center
1444
mi
from
Boston, MA
Click here to add this to my saved trials
Bortezomib in Treating Patients With Metastatic Thyroid Cancer That Did Not Respond to Radioactive Iodine Therapy
A Phase II Study of Bortezomib in Metastatic Papillary Thyroid Carcinoma or Follicular Thyroid Carcinoma
Status: Enrolling
Updated:  12/31/1969
Cleveland Clinic Foundation
898
mi
from
Cleveland, OH
Bortezomib in Treating Patients With Metastatic Thyroid Cancer That Did Not Respond to Radioactive Iodine Therapy
A Phase II Study of Bortezomib in Metastatic Papillary Thyroid Carcinoma or Follicular Thyroid Carcinoma
Status: Enrolling
Updated: 12/31/1969
Cleveland Clinic Foundation
898
mi
from
Cleveland, OH
Click here to add this to my saved trials
Bortezomib in Treating Patients With Metastatic Thyroid Cancer That Did Not Respond to Radioactive Iodine Therapy
A Phase II Study of Bortezomib in Metastatic Papillary Thyroid Carcinoma or Follicular Thyroid Carcinoma
Status: Enrolling
Updated:  12/31/1969
Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center
898
mi
from
Cleveland, OH
Bortezomib in Treating Patients With Metastatic Thyroid Cancer That Did Not Respond to Radioactive Iodine Therapy
A Phase II Study of Bortezomib in Metastatic Papillary Thyroid Carcinoma or Follicular Thyroid Carcinoma
Status: Enrolling
Updated: 12/31/1969
Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center
898
mi
from
Cleveland, OH
Click here to add this to my saved trials
Bortezomib in Treating Patients With Metastatic Thyroid Cancer That Did Not Respond to Radioactive Iodine Therapy
A Phase II Study of Bortezomib in Metastatic Papillary Thyroid Carcinoma or Follicular Thyroid Carcinoma
Status: Enrolling
Updated:  12/31/1969
The Ohio State University Comprehensive Cancer Center
810
mi
from
Columbus, OH
Bortezomib in Treating Patients With Metastatic Thyroid Cancer That Did Not Respond to Radioactive Iodine Therapy
A Phase II Study of Bortezomib in Metastatic Papillary Thyroid Carcinoma or Follicular Thyroid Carcinoma
Status: Enrolling
Updated: 12/31/1969
The Ohio State University Comprehensive Cancer Center
810
mi
from
Columbus, OH
Click here to add this to my saved trials
Bortezomib in Treating Patients With Metastatic Thyroid Cancer That Did Not Respond to Radioactive Iodine Therapy
A Phase II Study of Bortezomib in Metastatic Papillary Thyroid Carcinoma or Follicular Thyroid Carcinoma
Status: Enrolling
Updated:  12/31/1969
M D Anderson Cancer Center
572
mi
from
Houston, TX
Bortezomib in Treating Patients With Metastatic Thyroid Cancer That Did Not Respond to Radioactive Iodine Therapy
A Phase II Study of Bortezomib in Metastatic Papillary Thyroid Carcinoma or Follicular Thyroid Carcinoma
Status: Enrolling
Updated: 12/31/1969
M D Anderson Cancer Center
572
mi
from
Houston, TX
Click here to add this to my saved trials
Adrenal Function in Critical Illness
Adrenal Function in Critical Illness
Status: Enrolling
Updated:  12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
1123
mi
from
Bethesda, MD
Adrenal Function in Critical Illness
Adrenal Function in Critical Illness
Status: Enrolling
Updated: 12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
1123
mi
from
Bethesda, MD
Click here to add this to my saved trials
Recombinant Thyrotropin PET-CT Fusion Scanning in Thyroid Cancer
Utility of Recombinant Human Thyrotropin (rTSH) PET-CT Fusion Scanning to Identify Residual Well-differentiated Epithelial Thyroid Cancer
Status: Enrolling
Updated:  12/31/1969
Johns Hopkins Division of Endocrinology & Metabolism
1149
mi
from
Baltimore, MD
Recombinant Thyrotropin PET-CT Fusion Scanning in Thyroid Cancer
Utility of Recombinant Human Thyrotropin (rTSH) PET-CT Fusion Scanning to Identify Residual Well-differentiated Epithelial Thyroid Cancer
Status: Enrolling
Updated: 12/31/1969
Johns Hopkins Division of Endocrinology & Metabolism
1149
mi
from
Baltimore, MD
Click here to add this to my saved trials
Recombinant Thyrotropin PET-CT Fusion Scanning in Thyroid Cancer
Utility of Recombinant Human Thyrotropin (rTSH) PET-CT Fusion Scanning to Identify Residual Well-differentiated Epithelial Thyroid Cancer
Status: Enrolling
Updated:  12/31/1969
M.D. Anderson Cancer Center
572
mi
from
Houston, TX
Recombinant Thyrotropin PET-CT Fusion Scanning in Thyroid Cancer
Utility of Recombinant Human Thyrotropin (rTSH) PET-CT Fusion Scanning to Identify Residual Well-differentiated Epithelial Thyroid Cancer
Status: Enrolling
Updated: 12/31/1969
M.D. Anderson Cancer Center
572
mi
from
Houston, TX
Click here to add this to my saved trials
Recombinant Thyrotropin PET-CT Fusion Scanning in Thyroid Cancer
Utility of Recombinant Human Thyrotropin (rTSH) PET-CT Fusion Scanning to Identify Residual Well-differentiated Epithelial Thyroid Cancer
Status: Enrolling
Updated:  12/31/1969
Institute Gustave Roussy
4723
mi
from
Paris,
Recombinant Thyrotropin PET-CT Fusion Scanning in Thyroid Cancer
Utility of Recombinant Human Thyrotropin (rTSH) PET-CT Fusion Scanning to Identify Residual Well-differentiated Epithelial Thyroid Cancer
Status: Enrolling
Updated: 12/31/1969
Institute Gustave Roussy
4723
mi
from
Paris,
Click here to add this to my saved trials
Oral Contraceptives in the Metabolic Syndrome
Oral Contraceptives in the Metabolic Syndrome
Status: Enrolling
Updated:  12/31/1969
Virginia Commonwealth University General Clinical Research Center
1113
mi
from
Richmond, VA
Oral Contraceptives in the Metabolic Syndrome
Oral Contraceptives in the Metabolic Syndrome
Status: Enrolling
Updated: 12/31/1969
Virginia Commonwealth University General Clinical Research Center
1113
mi
from
Richmond, VA
Click here to add this to my saved trials
Hematopoietic Stem Cell Support in Patients With Refractory Sarcoidosis
Hematopoietic Stem Cell Transplant in Patients With Refractory Sarcoidosis: A Phase I/II Trial
Status: Enrolling
Updated:  12/31/1969
Northwestern University Feinberg School of Medicine
611
mi
from
Chicago, IL
Hematopoietic Stem Cell Support in Patients With Refractory Sarcoidosis
Hematopoietic Stem Cell Transplant in Patients With Refractory Sarcoidosis: A Phase I/II Trial
Status: Enrolling
Updated: 12/31/1969
Northwestern University Feinberg School of Medicine
611
mi
from
Chicago, IL
Click here to add this to my saved trials
Rare Genetic Disorders of the Breathing Airways
Rare Genetic Disorders of the Airways: Cross-sectional Comparison of Clinical Features, and Development of Novel Screening and Genetic Tests
Status: Enrolling
Updated:  12/31/1969
The Children's Hospital
408
mi
from
Denver, CO
Rare Genetic Disorders of the Breathing Airways
Rare Genetic Disorders of the Airways: Cross-sectional Comparison of Clinical Features, and Development of Novel Screening and Genetic Tests
Status: Enrolling
Updated: 12/31/1969
The Children's Hospital
408
mi
from
Denver, CO
Click here to add this to my saved trials
Rare Genetic Disorders of the Breathing Airways
Rare Genetic Disorders of the Airways: Cross-sectional Comparison of Clinical Features, and Development of Novel Screening and Genetic Tests
Status: Enrolling
Updated:  12/31/1969
National Jewish Health
407
mi
from
Denver, CO
Rare Genetic Disorders of the Breathing Airways
Rare Genetic Disorders of the Airways: Cross-sectional Comparison of Clinical Features, and Development of Novel Screening and Genetic Tests
Status: Enrolling
Updated: 12/31/1969
National Jewish Health
407
mi
from
Denver, CO
Click here to add this to my saved trials
Rare Genetic Disorders of the Breathing Airways
Rare Genetic Disorders of the Airways: Cross-sectional Comparison of Clinical Features, and Development of Novel Screening and Genetic Tests
Status: Enrolling
Updated:  12/31/1969
Laboratory of Clinical Infectious Diseases, NIAID
1123
mi
from
Bethesda, MD
Rare Genetic Disorders of the Breathing Airways
Rare Genetic Disorders of the Airways: Cross-sectional Comparison of Clinical Features, and Development of Novel Screening and Genetic Tests
Status: Enrolling
Updated: 12/31/1969
Laboratory of Clinical Infectious Diseases, NIAID
1123
mi
from
Bethesda, MD
Click here to add this to my saved trials
Rare Genetic Disorders of the Breathing Airways
Rare Genetic Disorders of the Airways: Cross-sectional Comparison of Clinical Features, and Development of Novel Screening and Genetic Tests
Status: Enrolling
Updated:  12/31/1969
University of North Carolina at Chapel Hill
1038
mi
from
Chapel Hill, NC
Rare Genetic Disorders of the Breathing Airways
Rare Genetic Disorders of the Airways: Cross-sectional Comparison of Clinical Features, and Development of Novel Screening and Genetic Tests
Status: Enrolling
Updated: 12/31/1969
University of North Carolina at Chapel Hill
1038
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Rare Genetic Disorders of the Breathing Airways
Rare Genetic Disorders of the Airways: Cross-sectional Comparison of Clinical Features, and Development of Novel Screening and Genetic Tests
Status: Enrolling
Updated:  12/31/1969
Children's Hospital and Regional Medical Center
1410
mi
from
Seattle, WA
Rare Genetic Disorders of the Breathing Airways
Rare Genetic Disorders of the Airways: Cross-sectional Comparison of Clinical Features, and Development of Novel Screening and Genetic Tests
Status: Enrolling
Updated: 12/31/1969
Children's Hospital and Regional Medical Center
1410
mi
from
Seattle, WA
Click here to add this to my saved trials
Rare Genetic Disorders of the Breathing Airways
Rare Genetic Disorders of the Airways: Cross-sectional Comparison of Clinical Features, and Development of Novel Screening and Genetic Tests
Status: Enrolling
Updated:  12/31/1969
Stanford University
1329
mi
from
Palo Alto, CA
Rare Genetic Disorders of the Breathing Airways
Rare Genetic Disorders of the Airways: Cross-sectional Comparison of Clinical Features, and Development of Novel Screening and Genetic Tests
Status: Enrolling
Updated: 12/31/1969
Stanford University
1329
mi
from
Palo Alto, CA
Click here to add this to my saved trials
Rare Genetic Disorders of the Breathing Airways
Rare Genetic Disorders of the Airways: Cross-sectional Comparison of Clinical Features, and Development of Novel Screening and Genetic Tests
Status: Enrolling
Updated:  12/31/1969
St. Michael's Hospital
1045
mi
from
Toronto,
Rare Genetic Disorders of the Breathing Airways
Rare Genetic Disorders of the Airways: Cross-sectional Comparison of Clinical Features, and Development of Novel Screening and Genetic Tests
Status: Enrolling
Updated: 12/31/1969
St. Michael's Hospital
1045
mi
from
Toronto,
Click here to add this to my saved trials
Rare Genetic Disorders of the Breathing Airways
Rare Genetic Disorders of the Airways: Cross-sectional Comparison of Clinical Features, and Development of Novel Screening and Genetic Tests
Status: Enrolling
Updated:  12/31/1969
Washington University
413
mi
from
Saint Louis, MO
Rare Genetic Disorders of the Breathing Airways
Rare Genetic Disorders of the Airways: Cross-sectional Comparison of Clinical Features, and Development of Novel Screening and Genetic Tests
Status: Enrolling
Updated: 12/31/1969
Washington University
413
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Continuation of Follow-up of DES-Exposed Cohorts
Continuation of Follow-up of DES-Exposed Cohorts
Status: Enrolling
Updated:  12/31/1969
Boston University School of Public Health
1443
mi
from
Boston, MA
Continuation of Follow-up of DES-Exposed Cohorts
Continuation of Follow-up of DES-Exposed Cohorts
Status: Enrolling
Updated: 12/31/1969
Boston University School of Public Health
1443
mi
from
Boston, MA
Click here to add this to my saved trials
Fat Cell Size in Insulin Resistance
Adipose Cell Size In Human Insulin Resistance
Status: Enrolling
Updated:  12/31/1969
National Institute of Diabetes and Digestive and Kidney Disorders (NIDDK), 9000
1123
mi
from
Bethesda, MD
Fat Cell Size in Insulin Resistance
Adipose Cell Size In Human Insulin Resistance
Status: Enrolling
Updated: 12/31/1969
National Institute of Diabetes and Digestive and Kidney Disorders (NIDDK), 9000
1123
mi
from
Bethesda, MD
Click here to add this to my saved trials
Effects of Thiazide Diuretics on Sympathetic Nervous System in Hypertension
Neural Mechanisms of Thiazide-induced Insulin Resistance
Status: Enrolling
Updated:  12/31/1969
UT Southwestern Medical Center
345
mi
from
Dallas, TX
Effects of Thiazide Diuretics on Sympathetic Nervous System in Hypertension
Neural Mechanisms of Thiazide-induced Insulin Resistance
Status: Enrolling
Updated: 12/31/1969
UT Southwestern Medical Center
345
mi
from
Dallas, TX
Click here to add this to my saved trials
Effects of Thiazide Diuretics on Sympathetic Nervous System in Hypertension
Neural Mechanisms of Thiazide-induced Insulin Resistance
Status: Enrolling
Updated:  12/31/1969
University of Texas Southwestern Medical Center
349
mi
from
Dallas, TX
Effects of Thiazide Diuretics on Sympathetic Nervous System in Hypertension
Neural Mechanisms of Thiazide-induced Insulin Resistance
Status: Enrolling
Updated: 12/31/1969
University of Texas Southwestern Medical Center
349
mi
from
Dallas, TX
Click here to add this to my saved trials
Role of Helicobacter Pylori and Its Toxins in Lung and Digestive System Diseases
Role of Helicobacter Pylori and Its Toxins in Pulmonary and Oropharyngeal Disease
Status: Enrolling
Updated:  12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
1123
mi
from
Bethesda, MD
Role of Helicobacter Pylori and Its Toxins in Lung and Digestive System Diseases
Role of Helicobacter Pylori and Its Toxins in Pulmonary and Oropharyngeal Disease
Status: Enrolling
Updated: 12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
1123
mi
from
Bethesda, MD
Click here to add this to my saved trials
Genetic Disorders of Mucociliary Clearance in Nontuberculous Mycobacterial Lung Disease
Genetic Disorders of Mucociliary Clearance
Status: Enrolling
Updated:  12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
1123
mi
from
Bethesda, MD
Genetic Disorders of Mucociliary Clearance in Nontuberculous Mycobacterial Lung Disease
Genetic Disorders of Mucociliary Clearance
Status: Enrolling
Updated: 12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
1123
mi
from
Bethesda, MD
Click here to add this to my saved trials
Effects of PTH Replacement on Bone in Hypoparathyroidism
Effects of PTH Replacement on Bone in Hypoparathyroidism
Status: Enrolling
Updated:  12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
1123
mi
from
Bethesda, MD
Effects of PTH Replacement on Bone in Hypoparathyroidism
Effects of PTH Replacement on Bone in Hypoparathyroidism
Status: Enrolling
Updated: 12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
1123
mi
from
Bethesda, MD
Click here to add this to my saved trials
Iodine I 131 in Treating Patients With Thyroid Cancer
Dose-Response in Radionuclide Therapy of Thyroid Cancer
Status: Enrolling
Updated:  12/31/1969
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
1149
mi
from
Baltimore, MD
Iodine I 131 in Treating Patients With Thyroid Cancer
Dose-Response in Radionuclide Therapy of Thyroid Cancer
Status: Enrolling
Updated: 12/31/1969
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
1149
mi
from
Baltimore, MD
Click here to add this to my saved trials
Transdermal Testosterone Gel/Effect on Erection Quality as Measured by DIR
Phase I Study of Transdermal Testosterone Gel and Its Effect on Erection Quality as Measured by a Digital Inflection Rigidometer (DIR)
Status: Enrolling
Updated:  12/31/1969
Steven Lamm, M.D.
1289
mi
from
New York, NY
Transdermal Testosterone Gel/Effect on Erection Quality as Measured by DIR
Phase I Study of Transdermal Testosterone Gel and Its Effect on Erection Quality as Measured by a Digital Inflection Rigidometer (DIR)
Status: Enrolling
Updated: 12/31/1969
Steven Lamm, M.D.
1289
mi
from
New York, NY
Click here to add this to my saved trials
Cholic Acid for Hepatic Steatosis in Lipodystrophy
Phase II Study of Cholic Acid for Hepatic Steatosis in Lipodystrophy Patients
Status: Enrolling
Updated:  12/31/1969
University of Texas Southwestern Medical Center
349
mi
from
Dallas, TX
Cholic Acid for Hepatic Steatosis in Lipodystrophy
Phase II Study of Cholic Acid for Hepatic Steatosis in Lipodystrophy Patients
Status: Enrolling
Updated: 12/31/1969
University of Texas Southwestern Medical Center
349
mi
from
Dallas, TX
Click here to add this to my saved trials
Novel Therapies for Metabolic Complications of Lipodystrophies
Novel Therapies for Metabolic Complications in Patients With Lipodystrophies
Status: Enrolling
Updated:  12/31/1969
U.T. Southwestern Medical Center
349
mi
from
Dallas, TX
Novel Therapies for Metabolic Complications of Lipodystrophies
Novel Therapies for Metabolic Complications in Patients With Lipodystrophies
Status: Enrolling
Updated: 12/31/1969
U.T. Southwestern Medical Center
349
mi
from
Dallas, TX
Click here to add this to my saved trials
Therapeutic Approaches to HAART-Induced Lipodystrophy
Therapeutic Approaches to HAART-Induced Lipodystrophy
Status: Enrolling
Updated:  12/31/1969
U.T. Southwestern Medical Center
349
mi
from
Dallas, TX
Therapeutic Approaches to HAART-Induced Lipodystrophy
Therapeutic Approaches to HAART-Induced Lipodystrophy
Status: Enrolling
Updated: 12/31/1969
U.T. Southwestern Medical Center
349
mi
from
Dallas, TX
Click here to add this to my saved trials
Photodynamic Therapy Using HPPH in Treating Patients Undergoing Surgery for Primary or Recurrent Head and Neck Cancer
A Phase I Study of Surgery Plus Intraoperative Photodynamic Therapy (PDT) in Patients With Resectable, Primary or Recurrent Head and Neck Cancer
Status: Enrolling
Updated:  12/31/1969
Roswell Park Cancer Institute
1057
mi
from
Buffalo, NY
Photodynamic Therapy Using HPPH in Treating Patients Undergoing Surgery for Primary or Recurrent Head and Neck Cancer
A Phase I Study of Surgery Plus Intraoperative Photodynamic Therapy (PDT) in Patients With Resectable, Primary or Recurrent Head and Neck Cancer
Status: Enrolling
Updated: 12/31/1969
Roswell Park Cancer Institute
1057
mi
from
Buffalo, NY
Click here to add this to my saved trials
5-Alpha Reductase and Anabolic Effects of Testosterone
5-Alpha Reductase and Anabolic Effects of Testosterone
Status: Enrolling
Updated:  12/31/1969
North Florida/South Georgia Veterans Health System
1048
mi
from
Gainesville, FL
5-Alpha Reductase and Anabolic Effects of Testosterone
5-Alpha Reductase and Anabolic Effects of Testosterone
Status: Enrolling
Updated: 12/31/1969
North Florida/South Georgia Veterans Health System
1048
mi
from
Gainesville, FL
Click here to add this to my saved trials
Effect of Diet on Vascular Disease in Pre-Menopausal Women
The Effect of Diet on Vascular Disease: A Study of African American and Caucasian Women
Status: Enrolling
Updated:  12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
1123
mi
from
Bethesda, MD
Effect of Diet on Vascular Disease in Pre-Menopausal Women
The Effect of Diet on Vascular Disease: A Study of African American and Caucasian Women
Status: Enrolling
Updated: 12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
1123
mi
from
Bethesda, MD
Click here to add this to my saved trials
Studying the Effects of 7 Days of Gonadotropin Releasing Hormone (GnRH) Treatment in Men With Hypogonadism
The Effects of 7 Days of Exogenous Pulsatile GnRH Treatment on the Pituitary-Gonadal Axis in Hypogonadotropic Hypogonadal Subjects
Status: Enrolling
Updated:  12/31/1969
Massachusetts General Hospital
1443
mi
from
Boston, MA
Studying the Effects of 7 Days of Gonadotropin Releasing Hormone (GnRH) Treatment in Men With Hypogonadism
The Effects of 7 Days of Exogenous Pulsatile GnRH Treatment on the Pituitary-Gonadal Axis in Hypogonadotropic Hypogonadal Subjects
Status: Enrolling
Updated: 12/31/1969
Massachusetts General Hospital
1443
mi
from
Boston, MA
Click here to add this to my saved trials
Studying the Effects of 7 Days of Gonadotropin Releasing Hormone (GnRH) Treatment in Men With Hypogonadism
The Effects of 7 Days of Exogenous Pulsatile GnRH Treatment on the Pituitary-Gonadal Axis in Hypogonadotropic Hypogonadal Subjects
Status: Enrolling
Updated:  12/31/1969
Massachusetts General Hospital
1443
mi
from
Boston, MA
Studying the Effects of 7 Days of Gonadotropin Releasing Hormone (GnRH) Treatment in Men With Hypogonadism
The Effects of 7 Days of Exogenous Pulsatile GnRH Treatment on the Pituitary-Gonadal Axis in Hypogonadotropic Hypogonadal Subjects
Status: Enrolling
Updated: 12/31/1969
Massachusetts General Hospital
1443
mi
from
Boston, MA
Click here to add this to my saved trials
Detection and Treatment of Endocrine Abnormalities in Childhood Cancer Survivors and Hematopoietic Stem Cell Transplant Recipients
Detection and Treatment of Endocrine Abnormalities in Childhood Cancer Survivors and Hematopoitic Stem Cell Transplant Recipients
Status: Enrolling
Updated:  12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
1123
mi
from
Bethesda, MD
Detection and Treatment of Endocrine Abnormalities in Childhood Cancer Survivors and Hematopoietic Stem Cell Transplant Recipients
Detection and Treatment of Endocrine Abnormalities in Childhood Cancer Survivors and Hematopoitic Stem Cell Transplant Recipients
Status: Enrolling
Updated: 12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
1123
mi
from
Bethesda, MD
Click here to add this to my saved trials
Vandetanib to Treat Children and Adolescents With Medullary Thyroid Cancer
Phase I/II Trial of Vandetanib (ZD6474, ZACTIMA) in Children and Adolescents With Hereditary Medullary Thyroid Carcinoma
Status: Enrolling
Updated:  12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
1123
mi
from
Bethesda, MD
Vandetanib to Treat Children and Adolescents With Medullary Thyroid Cancer
Phase I/II Trial of Vandetanib (ZD6474, ZACTIMA) in Children and Adolescents With Hereditary Medullary Thyroid Carcinoma
Status: Enrolling
Updated: 12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
1123
mi
from
Bethesda, MD
Click here to add this to my saved trials